Related Experiment Video
Updated: Jul 11, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Aortic valve stenosis: an active atheroinflammatory process.
Satu Helske1, Markku Kupari, Ken A Lindstedt
1Wihuri Research Institute, Helsinki, Finland. satu.helske@wri.fi
Current Opinion in Lipidology
|September 22, 2007
Summary
Aortic valve stenosis involves inflammation, lipids, and calcification, similar to atherosclerosis. Targeted therapies show promise for this actively regulated disease, with statins and renin-angiotensin system inhibitors as potential treatments.
Area of Science:
- Cardiovascular Pathology
- Molecular Biology
- Biomedical Research
Background:
- Aortic valve stenosis (AVS) is characterized by complex pathological processes.
- Understanding the molecular mechanisms driving AVS is crucial for developing effective treatments.
Purpose of the Study:
- To review current knowledge on the pathobiology of aortic valve stenosis.
- To highlight recent advancements in understanding AVS.
Main Methods:
- Review of current scientific literature on aortic valve stenosis.
- Analysis of cellular and molecular mechanisms involved in AVS.
Main Results:
- AVS exhibits atherosclerosis-like lesions with inflammatory cells, lipids, calcification, and bone formation.
- Extracellular matrix remodeling contributes to leaflet stiffening.
- Statins and renin-angiotensin system modulation show therapeutic potential in preclinical and clinical studies.
Conclusions:
- AVS is an actively regulated disease involving inflammatory, lipid, and calcification pathways.
- Targeted molecular therapies, including statins and renin-angiotensin system inhibitors, are promising avenues for AVS treatment.
- Further prospective clinical trials are needed to validate therapeutic strategies.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:38Inflammation
Overview